Microglia/Macrophage-Derived Inflammatory Mediators Galectin-3 and Quinolinic Acid are Elevated in Cerebrospinal Fluid from Newborn Infants After Birth Asphyxia

Translational Stroke Research

Volumn 4, Issue 2, 2013, Pages 228-235

  Sävman, Karin ^a,c   Heyes, Melvyn P ^b   Svedin, Pernilla ^a   Karlsson, Anna ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Cerebrospinal fluid galectin 3; Hypoxic ischemic brain injury; Microglia; Neonate; Quinolinic acid

Indexed keywords

GALECTIN 3; GELATINASE B; QUINOLINIC ACID;

ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MASS SPECTROMETRY; NEWBORN; NEWBORN HYPOXIA; NEWBORN INFECTION; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PERINATAL ASPHYXIA; PRIORITY JOURNAL; PROGNOSIS;

CEREBROSPINAL FLUID GALECTIN-3; HYPOXIC-ISCHEMIC BRAIN INJURY; MICROGLIA; NEONATE; QUINOLINIC ACID;

ASPHYXIA NEONATORUM; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALECTIN 3; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT, NEWBORN; MACROPHAGES; MALE; MICROGLIA; PROGNOSIS; QUINOLINIC ACID;

EID: 84875054379     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0216-3     Document Type: Article

References (56)

1. Volpe J. Hypoxic-ischemic encephalopathy; clinical aspects. Neurology of the Newborn. 5th Edition ed.; 2008. p. 440-84.
2. Savman K, Blennow M, Gustafson K, Tarkowski E, Hagberg H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res. 1998; 43(6): 746-51.
3. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K, et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res. 1999; 45(4 Pt 1): 500-9.
4. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol. 2002; 52(1): 54-61.
5. Dommergues MA, Plaisant F, Verney C, Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience. 2003; 121(3): 619-28.
6. Hagberg H, Gressens P, Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol. 2012; 71(4): 444-57.
7. Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight. Am J Obstet Gynecol. 1998; 179(2): 507-13.
8. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O'Sullivan F, Burton PR, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ. 1998; 317(7172): 1554-8.
9. Martin D, Chinookoswong N, Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol. 1994; 130(2): 362-7.
10. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci. 2002; 22(14): 5910-9.
11. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain. 1993; 116(Pt 6): 1425-50.
12. Guillemin GJ, Smythe G, Takikawa O, Brew BJ. Expression of indoleamine 2, 3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 2005; 49(1): 15-23.
13. Sankarapandi S, Zweier JL, Mukherjee G, Quinn MT, Huso DL. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch Biochem Biophys. 1998; 353(2): 312-21.
14. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson Jr WR. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol. 1995; 147(4): 1016-28.
15. Walther M, Kuklinski S, Pesheva P, Guntinas-Lichius O, Angelov DN, Neiss WF, et al. Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy. J Neurosci Res. 2000; 61(4): 430-5.
16. Hedtjarn M, Mallard C, Hagberg H. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 2004; 24(12): 1333-51.
17. Doverhag C, Hedtjarn M, Poirier F, Mallard C, Hagberg H, Karlsson A, et al. Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis. 2010; 38(1): 36-46.
18. Colnot C, Ripoche MA, Milon G, Montagutelli X, Crocker PR, Poirier F. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology. 1998; 94(3): 290-6.
19. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol. 2000; 156(3): 1073-83.
20. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol. 2000; 165(4): 2156-64.
21. Karlsson A, Follin P, Leffler H, Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood. 1998; 91(9): 3430-8.
22. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008; 180(4): 2650-8.
23. Lalancette-Hebert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng YC, et al. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J Neurosci. 2012; 32(30): 10383-95.
24. Johnston MV. Excitotoxicity in perinatal brain injury. Brain Pathol. 2005; 15(3): 234-40.
25. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993; 45(3): 309-79.
26. Stipek S, Stastny F, Platenik J, Crkovska J, Zima T. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem Int. 1997; 30(2): 233-7.
27. Heyes MP, Saito K, Chen CY, Proescholdt MG, Nowak Jr TS, Li J, et al. Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J Neurochem. 1997; 69(4): 1519-29.
28. Saito K, Seishima M, Noma A, Markey SP, Heyes MP. Cytokine and drug modulation of kynurenine pathway metabolism by blood mononuclear cells. Adv Exp Med Biol. 1996; 398: 161-5.
29. Heyes MP, Nowak Jr TS. Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil. J Cereb Blood Flow Metab. 1990; 10(5): 660-7.
30. Cozzi A, Carpenedo R, Moroni F. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3, 4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J Cereb Blood Flow Metab. 1999; 19(7): 771-7.
31. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 1992; 115(Pt 5): 1249-73.
32. Svedin P, Hagberg H, Savman K, Zhu C, Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci. 2007; 27(7): 1511-8.
33. Tsuji M, Wilson MA, Lange MS, Johnston MV. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol. 2004; 189(1): 58-65.
34. Imai F, Suzuki H, Oda J, Ninomiya T, Ono K, Sano H, et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab. 2007; 27(3): 488-500.
35. Levene MI, Sands C, Grindulis H, Moore JR. Comparison of two methods of predicting outcome in perinatal asphyxia. Lancet. 1986; 1(8472): 67-9.
36. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976; 33(10): 696-705.
37. Heyes MP, Markey SP. (18O)Quinolinic acid: its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid. Biomed Environ Mass Spectrom. 1988; 15(5): 291-3.
38. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet. 2003; 361(9359): 736-42.
39. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005; 365(9460): 663-70.
40. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. NEJM. 2005; 353(15): 1574-84.
41. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ. 1999; 319(7216): 1054-9.
42. Dobbie MS, Surtees RA. Concentrations of quinolinic acid in cerebrospinal fluid measured by gas chromatography and electron-impact ionisation mass spectrometry. Age-related changes in a paediatric reference population. J Chromatogr B: Biomed Sci Appl. 1997; 696(1): 53-8.
43. Heyes MP, Saito K, Milstien S, Schiff SJ. Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J Neurol Sci. 1995; 133(1-2): 112-8.
44. Savman K, Blennow M, Hagberg H, Tarkowski E, Thoresen M, Whitelaw A. Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta Paediatr. 2002; 91(12): 1357-63.
45. Sinz EH, Kochanek PM, Heyes MP, Wisniewski SR, Bell MJ, Clark RS, et al. Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans. J Cereb Blood Flow Metab. 1998; 18(6): 610-5.
46. Maliszewska M, Mader M, Scholl U, Azeh I, Hardeland R, Felgenhauer K, et al. Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid. J Neuroimmunol. 2001; 116(2): 233-7.
47. Fainardi E, Castellazzi M, Bellini T, Manfrinato MC, Baldi E, Casetta I, et al. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler. 2006; 12(3): 294-301.
48. Heyes MP, Morrison PF. Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues. J Neurochem. 1997; 68(1): 280-8.
49. Heyes MP, Quearry BJ, Markey SP. Systemic endotoxin increases l-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res. 1989; 491(1): 173-9.
50. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, Markey SP. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB. 1998; 12(10): 881-96.
51. Bell MJ, Kochanek PM, Heyes MP, Wisniewski SR, Sinz EH, Clark RS, et al. Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med. 1999; 27(3): 493-7.
52. Trescher WH, McDonald JW, Johnston MV. Quinolinate-induced injury is enhanced in developing rat brain. Brain Res Dev Brain Res. 1994; 83(2): 224-32.
53. Savman K, Nilsson UA, Thoresen M, Kjellmer I. Non-protein-bound iron in brain interstitium of newborn pigs after hypoxia. Dev Neurosci. 2005; 27(2-4): 176-84.
54. Ogihara T, Hirano K, Ogihara H, Misaki K, Hiroi M, Morinobu T, et al. Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy. Pediatr Res. 2003; 53(4): 594-9.
55. Whetsell Jr WO, Schwarcz R. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett. 1989; 97(3): 271-5.
56. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci. 2007; 27(10): 2596-605.